Czech National Bank Grows Holdings in Cardinal Health, Inc. (NYSE:CAH)

Czech National Bank grew its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 8.5% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 46,414 shares of the company’s stock after buying an additional 3,617 shares during the quarter. Czech National Bank’s holdings in Cardinal Health were worth $4,563,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Norges Bank bought a new stake in Cardinal Health in the 4th quarter worth approximately $258,499,000. California Public Employees Retirement System lifted its holdings in shares of Cardinal Health by 118.9% in the 4th quarter. California Public Employees Retirement System now owns 1,516,035 shares of the company’s stock worth $152,816,000 after acquiring an additional 823,520 shares during the last quarter. Acadian Asset Management LLC boosted its stake in shares of Cardinal Health by 19.1% in the 1st quarter. Acadian Asset Management LLC now owns 3,723,159 shares of the company’s stock valued at $416,585,000 after purchasing an additional 598,002 shares in the last quarter. Jupiter Asset Management Ltd. bought a new position in shares of Cardinal Health during the 1st quarter valued at $56,454,000. Finally, Jacobs Levy Equity Management Inc. raised its position in Cardinal Health by 265.6% in the 1st quarter. Jacobs Levy Equity Management Inc. now owns 657,526 shares of the company’s stock worth $73,577,000 after purchasing an additional 477,682 shares during the period. 87.17% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on CAH shares. StockNews.com lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Thursday. Argus dropped their target price on Cardinal Health from $120.00 to $115.00 and set a “buy” rating for the company in a report on Wednesday, May 15th. Citigroup lowered their price objective on Cardinal Health from $115.00 to $107.00 and set a “neutral” rating for the company in a research report on Friday, July 19th. Wells Fargo & Company dropped their price objective on Cardinal Health from $96.00 to $94.00 and set an “underweight” rating for the company in a research note on Monday, April 29th. Finally, Robert W. Baird lifted their target price on shares of Cardinal Health from $129.00 to $130.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 9th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $109.67.

Cardinal Health Price Performance

CAH stock traded up $1.10 during trading on Monday, reaching $101.77. The company had a trading volume of 221,044 shares, compared to its average volume of 2,126,452. The business has a 50 day moving average of $98.70 and a 200 day moving average of $103.21. The company has a market cap of $24.79 billion, a P/E ratio of 44.74, a PEG ratio of 1.14 and a beta of 0.61. Cardinal Health, Inc. has a 52 week low of $85.11 and a 52 week high of $116.04.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.